Replies to post #3255 on Galectin Therapeutics Inc. (GALT)

[thefamilyman]

I think they need to increase the dosage and that probably means reopening that Phase 1 trial for additional cohorts of 16 and 32. I don't anticipate any safety concerns and if they use patients with the disease as they did previously, then maybe the body of work will allow them to avoid another Phase 2 and go directly to Phase 3.